Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

DRUG:

Rexomun (ertumaxomab)

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Company:

Trion Pharma

Drug class:

HER2 inhibitor, CD3 inhibitor

Related drugs:

‹

trastuzumab biosimilar (0)

EGFR bi-armed autologous activated T cells (0)

muromonab-CD3 (0)

SLAMF7 FPBMC (0)

anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (0)

trastuzumab (407)

lapatinib (107)

neratinib (102)

trastuzumab-pkrb (24)

margetuximab-cmkb (18)

poziotinib (17)

zenocutuzumab-zbco (16)

mobocertinib (12)

trastuzumab-dttb (11)

zanidatamab-hrii (11)

trastuzumab-strf (9)

trastuzumab-anns (9)

trastuzumab-dkst (9)

trastuzumab-qyyp (9)

Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)

pertuzumab/trastuzumab/hyaluronidase-zzxf (3)

sunvozertinib (3)

trastuzumab/hyaluronidase-oysk (2)

JBJ-08–178–01 (2)

Hercease (trastuzumab biosimilar) (1)

HERtiCAD (trastuzumab biosimilar) (1)

Hervelous (trastuzumab biosimilar) (1)

EG12014 (trastuzumab biosimilar) (1)

sevabertinib (1)

TX05 (trastuzumab biosimilar) (1)

ALT02 (trastuzumab biosimilar) (0)

trastuzumab biosimilar (AP062) (0)

DA 3111 (trastuzumab biosimilar) (0)

HER-2/neu peptide vaccine (0)

HER2 t-haNK (0)

Hervycta (trastuzumab biosimilar) (0)

JNJ-26483327 (0)

diznalimgene lisbac (0)

MVA-BN-HER2 (0)

NeuCeptin (trastuzumab biosimilar) (0)

nelipepimut-S (0)

lapuleucel-T (0)

pertuzumab-dpzb (0)

trastuzumab biosimilar (SIBP-01) (0)

TAC100-HER2 (0)

glycooptimized trastuzumab-GEX (0)

TrastuRel (trastuzumab biosimilar) (0)

Undisclosed HER2Bi-armed ATC (0)

trastuzumab biosimilar (0)

trastuzumab biosimilar (0)

EGFR bi-armed autologous activated T cells (0)

muromonab-CD3 (0)

SLAMF7 FPBMC (0)

anti-CD3 x anti-CD20 bispecific antibody-armed activated T cells (0)

›